Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Mullerian tumours

Journal of Pathology

Volumn 183, Issue 4, 1997, Pages 424-431

  Abeln, Edwin C A ^a   Smit, Vincent T H B M ^a   Wessels, Johannes W ^a   De Leeuw, Wiljo J F ^a   Cornelisse, Cees J ^a,b   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Pathology ^*  (Netherlands)

Author keywords

Genetic heterogeneity; Loss of heterozygosity; Mixed Mullerian tumours; p53 mutation analysis

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53;

ARTICLE; CHROMOSOME 11; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME 3; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME ANALYSIS; GENE MAPPING; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; PHENOTYPE; PRIORITY JOURNAL; X CHROMOSOME;

AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, P53; HETEROZYGOTE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; MIXED TUMOR, MULLERIAN; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030726103     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199712)183:4<424::AID-PATH949>3.0.CO;2-L     Document Type: Article

References (26)

1. George E, Manivel JM, Dehner LP, Wick MR. Malignant mixed Müllerian tumours; an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation. Hum Pathol 1991; 22: 215-223.
2. Fortune DW, Östör AG. Mixed Müllerian tumours of the uterus. In: Fox H, ed. Obstetrical and Gynaecological Pathology. London: Churchill Livingstone, 1987; 457-478.
3. Meyer R. Mischgeschwiste des Uterus: die Komplizierten Tumouren. In: Henke F, Lubarsch O, eds. Handbuch der Speziellen Pathologischen Anatomie und Histologie. Berlin: Julius Springer, 1930; 412-415.
4. Emoto M, Iwasaki H, Kikuchi M, Shirakawa K. Characteristics of cloned cells of mixed Müllerian tumour of the human uterus. Cancer 1993; 71: 3065-3075.
5. Mayall F, Rutty K, Campbell F, Goddard H. p53 immunostaining suggests that uterine carcinosarcomas are monoclonal. Histopathology 1994; 24: 211-214.
6. De Brito PA, Silverberg SG, Orenstein JM. Carcinosarcoma [malignant mixed Müllerian (mesodermal) tumour] of the female genital tract: immunohistochemical and ultrastructural analysis. Hum Pathol 1993; 24: 132-142.
7. Ramadan M, Goudie RB. Epithelial antigens in malignant mixed mesodermal tumours of the uterus: a clinicopathologic and immunohistochemical study. J Pathol 1986; 148: 13-18.
8. Smit VTHBM, Cornelisse CJ, de Jong D, Dijkshoorn NJ, Peters AAW, Fleuren GJ. Analysis of tumour heterogeneity in a patient with synchronously occurring female genital-tract malignancies by DNA flow cytometry, DNA fingerprinting and immunohistochemistry. Cancer 1990; 62: 1146-1152.
9. Limpens J, Beelen M, Stad R, et al Detection of the t(14;18) translocation in frozen and formalin-fixed tissue. Diagn Mol Pathol 1993; 2: 99-107.
10. Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989; 44: 388-396.
11. Marakami Y, Hayashi S, Sekiya T. Aberrations of the tumour suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991; 51: 5520-5525.
12. Devilee P, Van Vliet M, Bardoel A, et al. Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res 1991; 51: 1020-1025.
13. van Elsas A, Zerp SF, van der Flier S, et al. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary cutaneous melanoma. Am J Pathol 1996; 149: 883-893.
14. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. Touchdown PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991; 19: 4008-4014.
15. Jacobs IJ, Kohler MF, Wiseman RW, et al. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J Natl Cancer Inst 1992; 84: 1793-1798.
16. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ. Endometrial intraepithelia carcinoma: a distinctive lesion specifically associated with tumours displaying serous differentiation. Hum Pathol 1995; 26: 1260-1267.
17. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumourigenesis. Hum Pathol 1995; 26: 1268-1274.
18. Echols H, Goodman MF. Fidelity mechanisms in DNA replication. Annu Rev Biochem 1991; 60: 477-511.
19. Costa MJ, Vogelsand J, Young LJT. p53 gene mutation female genital tract carcinosarcomas (malignant mixed Müllerian tumours): a clinico-pathologic study of 74 cases. Mod Pathol 1994; 7: 619-627.
20. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523-526.
21. Bitterman P, Chun B, Kurman RJ. The significance of epithelial differentiation in mixed mesodermal tumours of the uterus. Am J Surg Pathol 1990; 14: 317-328.
22. Silverberg SG, Major FJ, Blessing JA, et al. Carcinosarcoma (malignant mixed mesodermal tumour) of the uterus: a gynecologic oncology group pathologic study of 203 cases. Int J Gynecol Pathol 1990; 9: 1-19.
23. Sreenan JJ, Hart WR. Carcinosarcoma of the female genital tract, a pathologic study of 29 metastatic tumours: further evidence for the role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 1995; 19: 666-674.
24. Guarino M. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol Histopathol 1995; 10: 171-184.
25. Oberman HA. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 cases. Am J Surg Pathol 1987; 11: 918-929.
26. Ellis GL, Langloss L, Heffner DG, et al. Spindle cell carcinoma of the aerodigestive tract: an immunohistochemical analysts of 21 cases. Am J Surg Pathol 1987; 11: 335-342.